The departments of Health and Human Services and the Treasury have approved Section 1332 waivers for Wisconsin and Maine to implement five-year reinsurance programs for their individual health insurance markets beginning in 2019. The waivers are expected to lower premiums by about 11% in Wisconsin and 9% in Maine in 2019 and increase enrollment in coverage. Under Section 1332 of the Affordable Care Act, states can apply for a waiver of certain ACA requirements but must demonstrate that the proposed waiver would provide access to quality health care that is at least as comprehensive and affordable as without the waiver, and coverage to at least a comparable number of residents. HHS last year approved similar waivers for Oregon, Minnesota and Alaska. The ACA’s transitional reinsurance program to protect health plans in the individual market from unexpectedly high-cost enrollees under the law’s new insurance rules expired in 2016. AHA has encouraged the administration to approve state efforts to stabilize the health insurance marketplaces, and has urged Congress to create a federal reinsurance program and provide multi-year funding for cost-sharing reduction benefits to reduce premiums and stabilize the individual market for 2019 and beyond.

Related News Articles

Headline
The Centers for Medicare…
Headline
The National Institutes of Health today selected several universities to partner with communities in Kentucky, Massachusetts, New York and Ohio to study the…
Headline
Precancerous cervical lesions associated with human papillomavirus declined sharply in women aged 18–24 between 2008 and 2016, likely reflecting increasing HPV…
Headline
The Federal Trade Commission will hold a public workshop June 18 in Washington, D.C., to assess the impact of certificates of public advantage on health care…
Headline
The Medicaid and CHIP Payment and Access Commission yesterday recommended that Congress change the definition of Medicaid shortfall to exclude costs and…
Headline
The House Ways and Means Committee today approved the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act (H.R. 2113), AHA-supported…